2007
DOI: 10.1038/sj.gene.6364418
|View full text |Cite
|
Sign up to set email alerts
|

Association of NFKB1 −94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease

Abstract: Recently, a functional polymorphism in the NFKB1 gene promoter (À94ins/del ATTG) has been identified and associated with chronic inflammatory diseases. The aim of this study was to analyze the association of NFKB1 polymorphism with susceptibility to and phenotype of Graves' disease (GD). The initial case-control association study, performed in a Polish-Warsaw cohort (388 GD patients and 688 controls), was followed by the two replication studies performed in Polish-Gliwice and JapaneseKurume cohorts (198 GD pat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
28
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 41 publications
(30 citation statements)
references
References 35 publications
(44 reference statements)
2
28
0
Order By: Relevance
“…In the stomach, Lo et al (27) showed that the -94 deletion mutant had a significantly reduced risk for gastric carcinogenesis in China. Contrary to these results, several studies in Caucasians have shown that the -94 deletion mutant is associated with an increased risk for the development of inflammatory or auto-immune diseases (25,28). In colorectal carcinogenesis, Andersen et al (29) demonstrated that carriers of the NFKB1 -94 deletion were at a 1.45-fold higher risk than homozygous carriers of the insertion allele.…”
Section: Discussionmentioning
confidence: 65%
“…In the stomach, Lo et al (27) showed that the -94 deletion mutant had a significantly reduced risk for gastric carcinogenesis in China. Contrary to these results, several studies in Caucasians have shown that the -94 deletion mutant is associated with an increased risk for the development of inflammatory or auto-immune diseases (25,28). In colorectal carcinogenesis, Andersen et al (29) demonstrated that carriers of the NFKB1 -94 deletion were at a 1.45-fold higher risk than homozygous carriers of the insertion allele.…”
Section: Discussionmentioning
confidence: 65%
“…One of the most prominent polymorphisms known within the promoter of this gene is -94 ins/del ATTG rs28362491. A potential candidate for searching pathogenesis of inflammatory diseases, rs28362491, is shown to be associated with increased risk in rheumatoid arthritis [24], Graves's disease [25] and type 1 diabetes mellitus [26], whereas no associations with Hashimoto thyroiditis (HT) [27] and multiple sclerosis [28] have been yet shown. In addition, in American [13] and Dutch populations [29], rs28362491 in the NFKB1 gene was associated with UC development but not in Spanish [30] and British populations [31].…”
Section: Discussionmentioning
confidence: 99%
“…The functional polymorphism in the promoter region of NFKB1 gene is a four base ATTG insertion/deletion variant (-94ins/del ATTG, rs28362491), encodes three differential genotypes: wild-type homozygous insertion (ins/ins), variant homozygous deletion (del/del) and heterozygous (ins/del). The NFKB1-94ins/del ATTG polymorphism produces lower protein levels of p50, having been reported to correlate with many inflammatory diseases such as Grave’s disease, ulcerative colitis, and systemic lupus erythematosus [1113]. …”
Section: Introductionmentioning
confidence: 99%